 |
Journal articles
Omics studies: their use in diagnosis and reclassification of SLE and other systemic autoimmune diseases
Maria Teruel 1
Author
Chris Chamberlain 2
Author
Marta Alarcón-Riquelme 3
Author
J.O. Pers 4, 5
Author IdHAL : jacques-olivier-pers ORCID : https://orcid.org/0000-0001-7287-5541
1
CSIC - Spanish National Research Council (Consejo Superior de Investigaciones Cientificas, Madrid - Spain)
2
UCB Pharma [Slough] (Slough, Berkshire - United Kingdom)
- UCB Pharma [Brussels] (Allée de la Recherche, 60 B - 1070 Brussels - Belgium)
4
LabEX IGO Immunothérapie Grand Ouest (France)
5
CIC Brest (Boulevard Tanguy Prigent 29609 Brest Cedex - France)
- UBO - Université de Brest (Université de Bretagne Occidentale - 3 Rue des Archives 29238, Brest - France)
- INSERM - Institut National de la Santé et de la Recherche Médicale : CIC1412 (101, rue de Tolbiac, 75013 Paris - France)
- Hôpital de la Cavale Blanche (Boulevard Tanguy Prigent 29609 Brest Cedex - France)
Document type :
Journal articles
Complete list of metadata
https://hal.univ-brest.fr/hal-02051174
Contributor : Ghislaine Calvez Connect in order to contact the contributor
Submitted on : Wednesday, February 27, 2019 - 3:44:12 PM
Last modification on : Thursday, May 19, 2022 - 3:56:01 PM
Contributor : Ghislaine Calvez Connect in order to contact the contributor
Submitted on : Wednesday, February 27, 2019 - 3:44:12 PM
Last modification on : Thursday, May 19, 2022 - 3:56:01 PM
Identifiers
- HAL Id : hal-02051174, version 1
Collections
Citation
Maria Teruel, Chris Chamberlain, Marta Alarcón-Riquelme, J.O. Pers. Omics studies: their use in diagnosis and reclassification of SLE and other systemic autoimmune diseases. Rheumatology, Oxford University Press (OUP), 2017, pp.kew339. ⟨hal-02051174⟩
Metrics
Record views